NeuroPace Inc

NPCE

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001855616-26-000007
Filing date: Mar 4, 2026
Earliest execution date: Dec 15, 2025

Summary

Type

Sell

Net shares

-26,340

% of shares

-35.14%

Amount (USD)

$417,782

Insider confidence score

10.0 out of 100

Positive

  • Under Rule 10b5-1 trading plan

Negative

  • Extreme scheduled sell (≥25% of shares)
  • Large sell amount ($250K+)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2025-12-15

Code

S

Net shares

-25,000.0

Price per Share

$15.97

Amount (USD)

$399,250.00

Acquired/Disposed

Disposed

Shares Owned Before

74,964.0

Shares Owned After

49,964.0

Transaction 2

Security

Common Stock

Action

Tax_withhold

Date

2026-03-03

Code

F

Net shares

-1,340.0

Price per Share

$13.83

Amount (USD)

$18,532.20

Acquired/Disposed

Disposed

Shares Owned Before

49,964.0

Shares Owned After

48,624.0

Filing's footnotes

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes toprovide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.

3. Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.